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Patients with unilateral hearing loss have impaired hearing of sounds coming 
from the affected side, decreased comprehension of speech in noisy environments, 
and lack of sound localization. There are many conditions that can induce unilateral 
hearing loss, but idiopathic sudden sensorineural hearing loss (ISSHL) is thought to 
be most notable because of its high incidence. Patients with ISSHL suddenly acquire 
unilateral hearing loss; therefore, there are additional significant health problems 
that complicate the abovementioned symptoms due to the characteristic clinical 
course of ISSHL including hearing-related discomfort, tinnitus, and anxiety. It has 
been reported that hearing-related discomfort is closely associated with patients’ 
quality of life. In this chapter, the associated health issues of patients with ISSHL are 
described, and the interventions employed for patients with unilateral hearing loss 
are evaluated for their potential in improving the lives of ISSHL patients.
Keywords: idiopathic sudden sensorineural hearing loss, bone-anchored hearing 
aids, contralateral routing of signals, cochlear implant, hearing-related discomfort
1. Introduction
Because individuals with unilateral hearing loss have normal hearing in the 
opposite ear, impairment of auditory communication is less severe than in those 
with bilateral hearing loss. Therefore, interventions for these patients may not 
always be indicated. Unilateral hearing loss that is profound is known as single-
sided deafness (SSD). Patients with SSD suffer from impaired hearing of sounds 
coming from the deaf side, lack of sound localization, and deteriorated comprehen-
sion of speech in noisy environments. These disorders and related problems can 
affect academic performance in children. Kuppler et al. reviewed that some children 
with SSD have significantly decreased self-esteem and increased level of exhaus-
tion and stress because of the effort required to hear, and the tenfold increase of 
incidence (35%) of poor performer will be estimated [1]. It was also inferred that 
SSD have adverse effects on quality of life (QOL) and social life of both children 
and adults.
The causes of unilateral hearing loss include congenital and acquired diseases. 
Diseases inducing acquired unilateral hearing loss include idiopathic sudden 
sensorineural hearing loss (ISSHL), Meniere’s disease, mumps, vestibular schwan-
noma, otosclerosis, otitis media with effusion, chronic otitis media, and cholestea-
toma, among others. Hearing loss caused by otosclerosis, chronic otitis media, and 
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cholesteatoma can be improved by surgery, but inner ear damage resulting in SSD 
can rarely be reversed. Meniere’s disease usually presents with mild-to-moderate 
hearing loss. Vestibular schwannoma presents with a wide range of hearing loss, 
from normal to total deafness, and if the tumor grows, surgical treatment is 
required, but the possibility of inducing SSD is relatively high after surgery. Though 
mumps is a disease that can acutely cause SSD, the incidence of hearing complica-
tions in mumps patients is quite low. ISSHL is quite a common condition, and it is 
estimated to produce the most patients with irreversible unilateral hearing loss.
Patients with ISSHL have an extremely dramatic clinical course in which 
unilateral hearing loss suddenly develops from normal hearing on both sides. In 
addition to the hearing-related problems that patients with congenital unilateral 
hearing loss or gradually worsening unilateral hearing loss face, there are other 
subsequent health issues that arise; therefore, ISSHL could be considered the most 
significant cause of acquired unilateral hearing loss. This chapter focuses on ISSHL 
as a representative condition that induces acquired unilateral hearing loss. First, the 
symptoms and health issues of patients with ISSHL based on the results of a nation-
wide survey of patients with ISSHL in Japan will be described. Next, the therapeutic 
interventions for patients with irreversible unilateral hearing loss caused by ISSHL 
will be considered.
2. Epidemiology and frequency of ISSHL
ISSHL is the sudden or acute onset of sensorineural hearing loss of unknown 
origin. The hearing loss is unilateral in most cases with bilateral involvement 
reported in <5% of cases [2]. The lesion is most often cochlear in origin, and less 
frequently retrocochlear. Although the cause of ISSHL has not been identified, 
several pathogenic possibilities have been proposed, such as vascular disorders, 
viral infections, and membrane breaks. Many treatment regimens have been inves-
tigated, including corticosteroids, vasoactive drugs, antiviral drugs, and hyperbaric 
oxygenation therapy, but none have proven effective. ISSHL is expected to improve 
on its own or with treatment; however, hearing levels become fixed ~2 months from 
the onset, and if it is not cured by then, permanent hearing loss remains.
The incidence of ISSHL is reported to be 3-30 per 100,000 population per year 
[2], but a recent report in Japan reported 60 per 100,000 population per year [3]. 
According to the population of Japan, about 78,000 new cases occur annually. For 
the hearing performance of 1113 patients with ISSHL in the author’s hospital during 
the past 20 years during the persistent phase after treatment, 35% were completely 
cured, 27% had mild hearing loss, 26% had moderate hearing loss, 8% had severe 
hearing loss, and 4% had profound to total deafness. When this is considered with 
the above-estimated incidence, it is estimated that 21,000 patients with mild hearing 
loss, 20,000 patients with moderate hearing loss, 6200 patients with severe hearing 
loss, and 3100 patients with profound hearing loss develop unilateral hearing loss 
each year in Japan. Although vestibular schwannoma is also a relatively common dis-
ease inducing SSD, the number of surgeries performed annually in Japan to remove 
the tumors is estimated to be approximately 700 [4, 5], considerably less than the 
number of patients with SSD caused by ISSHL.
3. Symptoms and QOL in patients with ISSHL
Not many reports have investigated the symptoms or QOL in patients with 
ISSHL. Chiossoene-Kerdel et al. used the Hearing Handicap Inventory for Adults to 
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investigate the degree of handicap in patients with ISSHL [6], and most patients had 
a handicap associated with hearing loss and tinnitus. Carlsson et al. investigated 
QOL in patients with ISSHL using the EuroQoL-5D, Problems Impact Rating Scale, 
and the Hospital Anxiety and Depression Scale [7]. They reported that all three 
indicators were significantly influenced by the presence of tinnitus and vertigo. 
However, patients with Meniere’s disease may have been included in that report, 
because the incidence of vertigo at the time of investigation was quite high (34%). 
Two main symptoms were reported to affect QOL in ISSHL patients with persistent 
hearing problems: difficulty in hearing and tinnitus [6, 7]. Unilateral hearing loss is 
a sudden change for patients who have never experienced hearing problems before 
the onset of ISSHL. Other problems, such as hearing-related discomfort and anxiety 
about recurrence, may also affect QOL. These problems may differ from those in 
patients with congenital SSD.
I and a few others conducted a multicenter clinical study by the Acute Profound 
Deafness Research Committee of the Ministry of Health, Labour and Welfare in 
Japan to investigate the symptoms and QOL in the patients with ISSHL in their 
persistent phase [8, 9]. The results from that study are described below.
A total of 140 patients with ISSHL (64 males, 76 females; mean age 59.1 years; 
range 21–85 years) and 24 patients with congenital SSD (13 males, 11 females; mean 
age 30.5 years; range 20–77 years) were investigated to determine their symp-
toms. In the patients with ISSHL, hearing levels of the affected ear were widely 
distributed from normal to profound, with a peak distribution of 70 dBHL. The 
distribution of time intervals from the onset of hearing loss varied widely from 
30 days to 62 years (mean 5.5 years; median 2.7 years). The majority of patients 
with congenital SSD (71%) were between 20 and 29 years of age [8]. A symptom 
questionnaire was newly created to assess the patients’ symptoms. In a previous 
investigation, information on symptoms was elicited from 104 patients with ISSHL 
using a freewriting method. These symptoms were rewritten and organized to 
create a new questionnaire comprising 17 questions that covered seven categories: 
hearing difficulty (three questions), spatial hearing (two questions), hearing-
related discomfort (four questions), tinnitus (two questions), vertigo (one ques-
tion), attitude to communications (two questions), and anxiety (three questions). 
We also asked patients with congenital SSD to answer the same questionnaire and 
compared the results with those patients with ISSHL [8]. The results of four major 
hearing-related symptoms, hearing difficulty, disability of spatial hearing, discom-
fort, and tinnitus, are shown in Figure 1. In response to questions regarding hearing 
difficulty, patients in both groups reported that they frequently had problems. With 
regard to the items “conversation with several people” and “conversation in noisy 
place,” significantly more patients with ISSHL than with congenital SSD reported 
difficulty in hearing. In response to all questions regarding hearing-related discom-
fort, significantly more patients with ISSHL than with congenital SSD experienced 
symptoms. With respect to tinnitus, few patients with congenital SSD and many 
patients with ISSHL reported this symptom. In response to questions regarding 
spatial hearing, no difference between the groups was identified.
The health-related QOL in the patients with ISSHL and congenital SSD was 
investigated using the short-form health survey version 2 (SF-36). SF-36 pro-
vides scores for eight health-related QOL domains and two more comprehensive 
scores: the physical component summary (PCS) and the mental component 
summary (MCS). The scores for the eight domains and the two component 
summaries were standardized (norm-based scoring, Japanese average of 50, 
standard deviation of 10) for comparison with the scores of people in the general 
population or those reported in other studies. When the average scores for the 
two summary components in patients with ISSHL and those with congenital 
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SSD were compared with average Japanese scores matched by decade of age, the 
PCS scores in all age groups for both ISSHL and congenital SSD patients were 
not significantly different from the Japanese average scores, and MCS scores 
for patients in their 20s for both ISSHL and congenital SSD and in their 30s for 
ISSHL were not significantly different from Japanese average scores. However, 
the MCS scores for patients with ISSHL in their 40–70s were significantly lower 
than the age-matched average Japanese scores (Figure 2).
Next, multiple linear regression analysis was used to investigate confounders 
influencing MCS scores in patients with ISSHL. The effects of age, hearing level 
at the time of investigation, time from onset, and responses to three items of the 
symptom questionnaire (hearing difficulty in general, discomfort in noisy places, 
and tinnitus) were evaluated. Unexpectedly, the results showed that the response to 
the item of discomfort in noisy places was the sole significant confounder.
“Hearing-related discomfort” was not a particularly notable symptom before 
this study; therefore, we further investigated this finding. When the relationship 
between the response to the item “discomfort in noisy places” and the hearing level 
in the affected ear was investigated, the response was not associated with hearing 
level [8]. A high incidence of this symptom was reported by ISSHL patients with 
moderate to profound hearing loss in the affected ear. We can infer that people with 
moderate hearing loss feel discomfort from noise because they hear noisy sounds 
in the affected ear, which can be too loud as a result of recruitment phenomenon 
and can be distorted by impairment of frequency selectivity. But why do patients 
with profound hearing loss in their affected ear feel this discomfort? In the direct 
expression of the discomfort by the patients, some of them described it as “It feels 
very noisy because the noise around me spreads all over the space around me.” We 
proposed that the reason for this symptom in patients with unilateral profound 
hearing loss was sudden loss of the ability to localize the sounds coming from vari-
ous directions, and we called this condition “collapse of spatial hearing perception.” 
Figure 1. 
Four major categories of symptoms reported by patients with ISSHL and congenital SSD. This figure was 
created from the results of Sano et al. [8]. “Hearing difficulty” consists of three items, “disability of spatial 
hearing” consists of two items, and “hearing-related discomfort” consists of four items in the questionnaire. 
P-values are presented as a comparison of the incidence between ISSHL and congenital SSD: *p < 0.05, 
**p < 0.01.
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Individuals who had normal hearing in both ears before the onset of ISSHL sud-
denly lose the ability of spatial hearing, and they instantly begin and remain to feel 
discomfort in noisy environment. This symptom is important for understanding the 
QOL problems associated with ISSHL.
4.  Therapeutic interventions for irreversible unilateral sensorineural 
hearing loss caused by ISSHL
As mentioned earlier, patients with ISSHL have several hearing-related symp-
toms, which can be divided into four categories: hearing difficulty, disability 
of spatial hearing, discomfort, and tinnitus. Hearing difficulty includes several 
situations, such as conversation with several people and speech perception in noise. 
The efficacy of therapeutic interventions for patients with ISSHL needs to be evalu-
ated against those four categories. The available methods for evaluating those four 
categories are summarized in Table 1.
The degree of unilateral hearing loss caused by ISSHL varies from mild to 
profound, and the selection of interventions depends on the degree of hearing loss. 
The interventions for ISSHL patients with severe-to-profound hearing loss can be 
considered the same as those for SSD patients, which include cochlear implant (CI), 
bone-anchored hearing aids (BAHAs), and contralateral routing of signals (CROS) 
Figure 2. 
Mental component summary (MCS) scores of SF-36 in patients with ISSHL and congenital SSD. The graph 
was created using the data from Sano et al. [8]. “Japanese” indicates age-matched Japanese average scores. The 
results of 20s group of ISSHL and other than 20s groups of congenital SSD (CSSD) are not indicated because 
their numbers of patients were too small. P-values are presented as a comparison of scores between each age 
group of ISSHL or congenital SSD and the age-matched Japanese average: *p < 0.05, **p < 0.01.
Objective evaluation Subjective evaluation
Hearing difficulty Speech discrimination test SSQ/APHAB/GHABP
Spatial hearing Sound localization SSQ
Discomfort Not available Not available
Tinnitus Not available THI/VAS
SSQ , speech, spatial and qualities of hearing scale; APHAB, abbreviated profile of hearing aid benefit; GHABP, 
Glasgow hearing aid benefit profile; THI, tinnitus handicap inventory; VAS, visual analog scale.
Table 1. 
Evaluation methods for four major problems in patients with ISSHL.
Advances in Rehabilitation of Hearing Loss
6
hearing aid. If hearing loss is mild to moderate, a conventional air- conducted hear-
ing aid may be the primary treatment. These treatments are described below.
4.1 Therapeutic effects for patients with SSD
The methods for evaluating the therapeutic effects of interventions for patients 
with SSD have generally included sound localization test, speech comprehension in 
noise, and subjective evaluation. The effects of the BAHA, CROS hearing aid, and 
CI interventions are summarized below.
4.1.1 BAHA and CROS hearing aid
The BAHA and CROS hearing aid have essentially the same characteristics 
in that a microphone is placed on the affected ear side and the sound is heard in 
the normal ear. Whereas a BAHA transmits sound via bone conduction, a CROS 
hearing aid transmits sound to a receiver on the normal ear by wireless or wired 
transmission. The therapeutic effect of these hearing aids can be summarized from 
the results of two systematic reviews for adult-acquired SSD [10, 11].
For sound localization by BAHAs, Kim et al. [10] reported that the percent-
age of correct sound localization was 13–65.8% before BAHA implantation and 
15–68.5% after implantation, showing no significant difference in six studies. 
In a recent study, Agtrberg et al. [12] reported that BAHA neither improved nor 
deteriorated the localization abilities of patients with SSD. Kitterick et al. [11] 
reported that sound localization was not changed by CROS hearing aids in five 
studies and a significant deficit was indicated in one study. Therefore, it can be 
concluded that there is no improvement in sound localization with BAHAs or 
CROS hearing aids.
Speech comprehension in noise improves under certain conditions. Kim et al. 
[10] reported that in the situation of speech coming from the front and noise com-
ing from the normal ear side, speech discrimination was statistically significantly 
improved after BAHA implantation in four out of six studies. Kitterick et al. [11] 
conducted a meta-analysis using data from the Hearing in Noise Test. A significant 
benefit was identified in the situation of speech coming from the front and noise 
coming from the normal ear side for both BAHAs and CROS hearing aids; however, 
a significant deficit was identified for both devices in the situation of noise com-
ing from the affected ear side. The effects of BAHAs and CROS hearing aids are 
generally similar, with the former thought to be slightly superior. For the subjective 
evaluation of the benefits and adverse effects of the interventions, the abbreviated 
profile of hearing aid benefit (APHAB) and the Glasgow hearing aid benefit profile 
(GHABP) have been widely used. Kitterick et al. conducted a meta-analysis using 
data from the APHAB before and after the use of BAHAs and CROS hearing aids. 
Significant benefits of the BAHA were found for three subscales, reverberation, 
ease of communication, and background noise, but not for aversion to loud sound. 
Significant benefits of the CROS hearing aid were also found for two subscales: 
background noise and reverberation.
4.1.2 Cochlear implant
CI is a method of treating the deaf ear itself so that it can regain hearing ability. 
Therefore, the treatment concept is essentially different from the BAHA and CROS 
hearing aid. A study of CI for adult-acquired SSD was reviewed. Two systematic 
reviews [13, 14] and several subsequent reports [15–18] yielded similar results. 
These are summarized as follows.
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For sound localization, Kitterick et al. [11] reported that only one of the three 
studies showed statistically significant improvement after CI surgery. Although 
most of studies reported improvement of sound localization after CI, a meta-
analysis could not be conducted because of heterogeneous methodologies.
For speech comprehension in noise, Blasco and Redleaf [12] conducted a meta-
analysis and reported in the situation where both speech and noise were coming from 
the front; the signal-to-noise ratio for speech perception in noise was significantly 
improved following CI. However, in the situation where speech was coming from the 
front and noise was coming from the affected side, no improvement was observed.
For the subjective evaluation, Kitterick et al. [11] conducted a meta-analysis 
using data from the speech, spatial and qualities of hearing scale (SSQ ) [19]. They 
found significant improvement for all three subscales: speech, spatial, and “other” 
qualities.
For the subjective evaluation of severity of tinnitus, Blasco and Redleaf [13] 
conducted a meta-analysis using a visual analog scale from three studies and found 
statistically significant improvement following CI implantation.
Overall, an important difference in the results of CI from those of the BAHA and 
CROS hearing aid is that there was a possibility of improvement for sound localiza-
tion and spatial hearing ability. It is considered that these two factors are associated 
with each other. In addition, Legaris et al. reported that cortical reorganization 
and restoration of binaural function in the brain might be produced after 1 year of 
experience with CI in adult SSD patients by evaluation of cortical auditory evoked 
potential changes [20].
4.2  Potential of interventions for ISSHL patients with severe-to-profound 
hearing loss
BAHAs and CROS hearing aids improve hearing from the deaf side. 
Improvement in speech comprehension in noise can be expected when the speech 
comes from the deaf side or front and the noise comes from the normal ear side. 
However, the ability for sound localization cannot be expected, and it is not possible 
to restore spatial hearing function. Therefore, among the associated problems for 
patients with ISSHL with severe-to-profound hearing loss, both devices seem to 
give no benefit for spatial hearing, discomfort, or tinnitus.
A CI improves speech comprehension in noise at least as well as the BAHA or 
CROS hearing aid. A CI also seems to have potential to improve sound localization, 
which could lead to restoration of spatial hearing ability. The SSQ subjective evalu-
ation contains many assessment items related to spatial hearing [19], and the scores 
of spatial hearing were reported to improve after cochlear implantation. Although 
there have been no reports directly evaluating “hearing-related discomfort” as an 
important symptom of ISSHL, it may be improved if spatial hearing ability can be 
restored. Direct evaluation of this symptom is needed in future assessments. Patients 
with tinnitus can also be expected to experience improvement with a CI [13, 15, 18]. 
Overall, although further investigation is needed, a CI has the potential to improve 
speech comprehension in noise, spatial hearing, and tinnitus and may also improve 
discomfort. The indication of CI in patients with ISSHL is the confirmation of cochlear 
pathogenesis, and relatively early surgery after ISSHL onset should be considered [18].
4.3  Potential of interventions for ISSHL patients with mild-to-moderate  
hearing loss
Conventional hearing aids are indicated for ISSHL patients with unilateral mild-
to-moderate hearing loss. However, patients with mild-to-moderate hearing loss on 
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the affected ear and normal hearing on the opposite ear are less likely to realize the 
benefits of hearing aids on the affected ear and are often unable to wear them. Since 
some degree of auditory function remains in the affected ear, symptoms such as diffi-
culty in hearing and impaired sound localization are milder than in patients with SSD, 
and, as a result, the beneficial effect of wearing a hearing aid seems to be difficult to 
perceive subjectively and to detect objectively. In addition, Kumpik et al. reviewed 
from several studies that horizontal localization by adult humans can adapt to varying 
degree to asymmetric hearing loss induced by occluding one ear [21]. Therefore, the 
abilities of sound localization and spatial hearing may be spontaneously restored in 
some degree in the patients with unilateral mild-to-moderate hearing loss. There do 
not seem to be any previous reports that examined the effect of hearing aids for hear-
ing disability in patients with unilateral mild-to-moderate hearing loss.
Hearing-related discomfort is also common in ISSHL patients with unilateral 
moderate hearing loss, but the mechanism may differ from that in patients with 
unilateral severe-to-profound hearing loss. Patients with moderate hearing loss 
are more likely to have discomfort with sounds heard on the affected side, that 
is, increased loudness of noise caused by the recruitment phenomenon or distor-
tion caused by the impairment of frequency selectivity function is unpleasant. 
Therefore, it is unlikely that a hearing aid will improve excessive loudness and 
distortion of sound.
On the other hand, tinnitus symptoms are more common in patients with mild-
to-moderate hearing loss due to ISSHL. Tinnitus retraining therapy using a hearing 
aid as a means of sound therapy has been widely conducted. At present, there is 
no high-quality evidence from systematic reviews [22], but improvement in the 
Tinnitus Handicap Inventory or visual analog scales has been widely recognized. In 
the future, it will be necessary to establish evidence of tinnitus improvement and to 
evaluate speech comprehension in noise and sound localization as well as hearing-
related discomfort in ISSHL patients with mild-to-moderate hearing loss.
5. Summary
ISSHL is an important cause of persistent unilateral sensorineural hearing loss 
that affects thousands of new patients annually in Japan. The problems caused 
by ISSHL can be categorized into four factors: hearing difficulty, deterioration 
of spatial hearing, hearing-related discomfort, and tinnitus. The interventions 
that have been used to treat patients with unilateral hearing loss can be adapted to 
patients with ISSHL. The expected benefits of interventions for ISSHL patients are 
shown in Table 2. Although there are presently no treatments that provide satisfac-
tory outcomes, CI is possibly the current most effective means of restoring some 
Grade of hearing loss Severe-deaf Mild-moderate
Intervention BAHA/CROS CI Conventional HA
Speech in noise Partially improved Partially improved ?
Spatial hearing → Possibly improved ?
Discomfort ? ? ?
Tinnitus → Improved Improved
BAHA, bone-anchored hearing aid; CROS, contralateral routing of signals; CI, cochlear implant; HA, hearing aid; 
→, not improved; ?, not available for applicable investigations.
Table 2. 
Expected effect of interventions for patients with ISSHL.
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of the lost binaural functions in patients with ISSHL who have severe-to-profound 
hearing loss. On the contrary, the effect of BAHA and CROS is quite restricted for 
such patients.
In the future, it will be necessary to unify evaluation methods for sound localiza-
tion, speech comprehension in noise, and subjective questionnaires. Health-related 
QOL should be a component of the subjective assessments, and “hearing-related 
discomfort,” which negatively impacts QOL for ISSHL patients, must be included as 
a subjective evaluation item.
Conflict of interest
The author has no conflict of interest to declare.
Author details
Hajime Sano
Department of Rehabilitation, School of Allied Health Sciences,  
Kitasato University, Japan
*Address all correspondence to: sanohj@med.kitasato-u.ac.jp
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
10
Advances in Rehabilitation of Hearing Loss
[1] Kuppler K, Lewis M, Abdele KE.  
A review of unilateral hearing loss 
and academic performance: Is it time 
to reassess traditional dogmata? 
International Journal of Pediatric 
Otorhinolaryngology. 2013;77:617-612. 
DOI: 10.1016/1.ijporl.2013.01.014
[2] Schreiber BE, Agrup C, 
Haskard DO, Luxon LM. Sudden 
sensorineural hearing loss. Lancet. 
2010;375:1203-1211. DOI: 10.1016/
S0140-6736(09)62071-7
[3] Nakashima T, Sato H, Gyo K, Hato N, 
et al. Idiopathic sensorineural hearing 
loss in Japan. Acta Oto-Laryngologica. 
2014;134:1158-1163. DOI: 
10.3109/00016489.2014.919406
[4] Babu R, Sharma R, Bagley JB, Hatef 
J, Friedman AH, Adamson C. Vestibular 
schwannomas in the modern era: 
Epidemiology, treatment trends, and 
disparities in management. Journal of 
Neurosurgery. 2013;119:121-130. DOI: 
10.3171/2013.1.JNS121370 Epub: 22 
February 2013
[5] Hahimoto S. Epidemiology 
and pathophysiology of vestibular 
schwannoma—Current concept. 
Jikotokei. 2016;88:994-999 (Japanese)
[6] Chiossoene-Kerdel JA, Bagley DM, 
Stoddart RL, et al. An investigation of 
the audiologic handicap associated with 
unilateral sudden sensorineural hearing 
loss. The American Journal of Otology. 
2000;21:645-651
[7] Carlsson PI, Hall M, Lind KJ, 
et al. Quality of life, psychosocial 
consequences, and audiological 
rehabilitation after sudden 
sensorineural hearing loss. International 
Journal of Audiology. 2011;50:139-144. 
DOI: 10.3109/14992027.2010.533705
[8] Sano H, Okamoto M, Ohhashi K, Ino 
T, Iwasaki S, Ogawa K. Self-reported 
symptoms in patients with idiopathic 
sudden sensorineural hearing 
loss. Otology & Neurotology. 
2013;34:1405-1410. DOI: 10.1097/
MAO.0b013e3182a03705
[9] Sano H, Okamoto M, Ohhashi K, 
Iwasaki S, Ogawa K. Quality of life 
reported by patients with idiopathic 
sudden sensorineural hearing loss. 
Otology & Neurotology. 2012;34:36-40. 
DOI: 10.1097/MAO.0b013e318278540e
[10] Kim G, Ju HM, Lee SH, Kim HS, 
Kwon JK, Seo YJ. Efficacy of bone-
anchored hearing aids in single-sided 
deafness: A systematic review. Otology 
& Neurotology. 2017;38:473-483. DOI: 
10.109/MAO.000000000001359
[11] Kitterick PT, Smith SN, Lucas L.  
Hearing instruments for unilateral 
severe-to-profound sensorineural 
hearing loss in adults: A systematic 
review and meta-analysis. Ear and 
Hearing. 2016;37:495-507. DOI: 10.1097/
AUD.0000000000000313
[12] Agtrberg MJH, Snik AFM, Van 
de Goor RMG, Hol MKS, Van Opstal 
AJ. Sound localization performance of 
patients with single-side deafness is not 
improved when listening with a bone-
conduction device. Hearing Research. 
2019;372:62-68. DOI: 10.1016/j.
heares.2018.04.007. Epub: 19 April 2018
[13] Blasco MA, Redleaf MI. Cochlear 
implantation in unilateral sudden 
deafness improves tinnitus and 
speech comprehension: Meta-analysis 
and systematic review. Otology & 
Neurotology. 2014;35:1426-1432. DOI: 
10.1097/MAO.0000000000000431
[14] Grossmann W, Brill S, Moeltner A,  
Mlynski R, Hagen R, Radeloff A. 
Cochlear implantation improves spatial 
release from masking and restores 
localization abilities in single-sided 
deaf patients. Otology & Neurotology. 
References
11




[15] Louza J, Hempel JM, Krause E, 
Berghaus A, Muller J, Braun T.  
Patient benefit from cochlear 
implantation in single-sided deafness: 
A 1-year follow-up. European 
Archives of Oto-Rhino-Laryngology. 
2017;27:2405-2409. DOI: 10.1097/
MAO.0000000000000841
[16] Buss E, Dillon MT, Rooth MA, 
King ER, Deres EJ, Buchman CA, 
et al. Effects of cochlear implantation 
on binaural hearing in adults with 
unilateral hearing loss. Trends in 
Hearing. 2018;22:2331216518771173. 
DOI: 10.1177/2331216518771173
[17] Prejban DA, Hamzavi JS, Arnoldner 
C, Liepins R, Honeder C, Keider A, 
et al. Single sided deaf cochlear implant 
users in the difficult listening situation: 
Speech perception and subjective 
benefit. Otology & Neurotology. 
2018;39:e803-e809. DOI: 10.1097/
MAO.0000000000001963
[18] Lin YW, Cheng X, Chen B, Peng 
K, Ishiyama A, Fu Q  J. Effect of 
tinnitus and duration of deafness 
on sound localization and speech 
recognition in noise in patients with 
single-side deafness. Trends in Hearing. 
2018;22:2331216518813802. DOI: 
10.1177/2331216518813802
[19] Gatehouse S, Noble W. The speech, 
spatial and qualities of hearing scale 
(SSQ ). International Journal of 
Audiology. 2004;43:85-99
[20] Legaris E, Galvin J, Roux S, 
Gomot M, Aoustin JM, Marx M. 
Cortical reorganization after 
cochlear implantation for adults with 
single-sided deafness. PLoS ONE; 
2018;13:e0204402. DOI: 10.1371/
journal.pone.0204402
[21] Kupik DP, King AJ. A review of 
the effects of unilateral hearing loss 
on spatial hearing. Hearing Research. 
2019;372:17-28. DOI: 10.1016/j.
heres.2018.08.003
[22] Sereda M, Xia J, EI Refaie A, 
Hall DA, Hoare DJ. Sound therapy 
(using amplification devices and/
or sound generators) for tinnitus. 
Cochrane Database of Systematic 
Reviews. 2018;27(12):CD013094. DOI: 
10.1002/14651858.CD013094.pub2
